Tulio E. Rodriguez

Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial

Francisco M. Marty, Per Ljungman, Genovefa A. Papanicolaou et al. · The Lancet Infectious Diseases · 2011 · 350 citations

Medicine, Hematology, Infectious Diseases +17

Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure

Paul G. Richardson, Marcie Riches, Nancy A. Kernan et al. · Blood · 2016 · 327 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +7

Prevention of Nausea and Vomiting Associated with Stem Cell Transplant: Results of a Prospective, Randomized Trial of Aprepitant Used with Highly Emetogenic Preparative Regimens

Patrick J. Stiff, Mary Fox-Geiman, Karen Kiley et al. · Biology of Blood and Marrow Transplantation · 2012 · 66 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

TNF-Inhibition with Etanercept for Graft-versus-Host Disease Prevention in High-Risk HCT: Lower TNFR1 Levels Correlate with Better Outcomes

Sung Won Choi, Patrick J. Stiff, Kenneth R. Cooke et al. · Biology of Blood and Marrow Transplantation · 2012 · 61 citations · Full text

Life Sciences, Hematology, Immunology +17

Tandem Autologous Stem Cell Transplantation for Patients with Primary Refractory or Poor Risk Recurrent Hodgkin Lymphoma

Henry C. Fung, Patrick J. Stiff, Jeff Schriber et al. · Biology of Blood and Marrow Transplantation · 2007 · 56 citations · Full text

Medicine, Oncology, Cell Therapy +14